Literature DB >> 19032780

H-index, mentoring-index, highly-cited and highly-accessed: how to evaluate scientists?

Kuan-Teh Jeang.   

Abstract

How best to evaluate scientists within a peer group is a difficult task. This editorial discusses the use of the H-index and total citations. It also raises the consideration of a mentoring-index and the value of understanding the frequency that a published paper is accessed by readers.

Entities:  

Mesh:

Year:  2008        PMID: 19032780      PMCID: PMC2607307          DOI: 10.1186/1742-4690-5-106

Source DB:  PubMed          Journal:  Retrovirology        ISSN: 1742-4690            Impact factor:   4.602


Editorial

Key performance indicators

A challenging question in peer-reviewed science is how to distribute judiciously resources amongst a large number of competing researchers. What are the "key performance indicators" that should be used to evaluate scientists who pursue similar research interests? One popular discussion is to ask how many times a person has published articles in journals with a high impact factor (IF). Several "quirks" in the way that a journal's IF is calculated have prompted many individuals to question whether this number reliably reflects the citation frequency of research articles that are published in the journal [1]. Recently, a scientist's H-index (HI) [2] has been suggested as a more informative measure of his/her scientific productivity [1].

H-index and total citations

The predictive value of the HI does have limitations [3]. However, in a 2007 survey of Retrovirology editorial board members, it was noted that an individual's H-number correlated well with the absolute frequency that his/her published papers were cited in the scientific literature [1]. A mid-October 2008 update of the 2007 survey, using numbers from the Scopus database , continues to support this correlation (Table 1). Thus, within a well-delimited field of research, a scientist's HI and his/her total citations appear to be reasonably quantitative peer-measures, seemingly superior to the colloquial banters about "high impact" papers. It should be noted that different databases measure HI numbers over varying time periods, and are not directly comparable. In general, a HI number increases with the length of time over which it is measured; hence, older scientists would usually be expected to sport HI numbers higher than their younger counterparts
Table 1

H-index and citation frequencies of selected Retrovirology editorial board members.

TitleNameRole within RetrovirologyInstitutionCityCountryH indexTotal times cited since 1996
Dr.Kuan-Teh JeangEditor-in-ChiefNIHBethesdaUSA439082

Dr.Monsef BenkiraneEditorCNRSMontpellierFrance201751

Dr.Ben BerkhoutEditorAcademic Med. CtrAmsterdamthe Netherlands386022

Dr.Andrew ML LeverEditorCambridge UniversityCambridgeUK191919

Dr.Mark WainbergEditorMcGill UniversityMontrealCanada399519

Dr.Masahiro FujiiEditorNiigata UniversityNiigataJapan191686

Dr.Michael LairmoreEditorOhio State UniversityColumbusUSA201933

Dr.Michael BukrinskyEd BoardGeorge Washington UnivWashington DCUSA254913

Dr.Dong-yan JinEd BoardHong Kong UHong KongChina222402

Dr.Klaus StrebelEd BoardNIHBethesdaUSA253889

Dr.Tom J. HopeEd BoardU. IllinoisChicagoUSA264307

Dr.Ariberto FassatiEd BoardUniversity CollegeLondonEngland11524

Dr.Stephane EmilianiEd BoardCochin InstituteParisFrance171774

Dr.Patrick GreenEd BoardOhio StateColumbusUSA17918

Dr.Mauro GiaccaEd BoardInt. Ctr. GeneticsTriesteItaly355051

Dr.Olivier SchwartzEd BoardInstitut PasteurParisFrance273657

Dr.Leonid MargolisEd BoardNational Inst Child HealthBethesdaUSA221745

Dr.Fatah KashanchiEd BoardGeorge Washington U.Washington DCUSA262503

Dr.Masao MatsuokaEd BoardKyoto UniversityKyotoJapan241992

Dr.Naoki MoriEd BoardUniversity of the RyukyusOkinawaJapan241982

Dr.Chou-Zen GiamEd BoardUniform Services Med SchoolBethesdaUSA141454

Dr.David DerseEd BoardNCIFrederickUSA131667

Dr.Tatsuo ShiodaEd BoardOsaka UnivOsakaJapan241956

Dr.John SemmesEd BoardEastern Virginia Med CollegeNorfolkUSA272953

Dr.Anne GatignolEd BoardMcGill Univ.MontrealCanada141012

Dr.Rogier SandersEd BoardAcademic Med Ctr.Amsterdamthe Netherlands13845

Dr.Chen LiangEd BoardMcGill Univ.MontrealCanada19915

Dr.Finn Skou PedersenEd BoardUniversity of AarhusAarhusDenmark191490

Dr.Janice ClementsEd BoardJohns Hopkins Med SchoolBaltimoreUSA233454

Dr.Renaud MahieuxEd BoardPasteur InstParisFrance231312

Dr.Chris AikenEd BoardVanderbilt UniversityNashvilleUSA182347

Dr.Neil AlmondEd BoardNIBSCPotters BarUK121121

Dr.Stephen P. GoffEd BoardColumbia UniversityNew YorkUSA4113771

Dr.Johnson MakEd BoardBurnet Inst. Med. ResearchVictoriaAustralia151298

Dr.Christine KozakEd BoardNIHBethesdaUSA297489

Dr.Greg TowersEd BoardUniversity CollegeLondonUK171392

Dr.Graham TaylorEd BoardImperial CollegeLondonUK151567

Dr.Eric CohenEd BoardUniv. MontrealMontrealCanada273221

Dr.William HallEd BoardUniversity College DublinDublinIreland212071

Dr.Warner GreeneEd BoardUCSFSan FranciscoUSA3910133

Dr.Jean-luc DarlixEd BoardU. LyonLyonFrance325654

Dr.Axel RethwilmEd BoardU. WuerzburgWuerzburgGermany222040

Dr.Eric FreedEd BoardNCIFrederickUSA294415

Dr.Toshiki WatanabeEd BoardUniv. of TokyoTokyoJapan222167

Dr.Mari KannagiEd BoardTokyo Med and Dental UTokyoJapan151350

Dr.Frank KirchhoffEd BoardUniversity of UlmUlmGermany304520

Dr.Jennifer NyborgEd BoardColorado State UFort CollinsUSA171571

Dr.Akifumi Takaori-KondoEd BoardKyoto UniversityKyotoJapan13589

Dr.Marc SitbonEd BoardCNRSMontpellierFrance12690

Dr.Paul GorryEd BoardMacFarlane Burnet InstituteMelbourneAustralia13607

Dr.David HarrichEd BoardQueensland Inst Medical Res.BrisbaneAustralia121000

Dr.Susan MarriottEd BoardBaylorHoustonUSA141021

Dr.Damian PurcellEd BoardU MelbourneMelbourneAustralia12902

Dr.Alan CochraneEd BoardU TorontoTorontoCanada101080

Dr.Yiming ShaoEd BoardChina CDCBeijingChina13977

Dr.Vinayaka PrasadEd BoardAlbert Einstein College MedicineNew YorkUSA181187
H-index and citation frequencies of selected Retrovirology editorial board members.

A time for a mentoring-index?

Scientists do research and also mentor younger colleagues. Good mentoring should be a significant consideration of one's contribution to science. The HI might measure research productivity, but currently there does not appear to be a "mentoring index" (MI). Accepting that mentoring is an important component of a scientist's career, one could propose to construct a MI derived as a composite value based on the current HI of trainees during an earlier period with a given mentor. For example, a MI for scientist X reflecting his/her mentoring influence during the 1991 to 1995 period could be calculated from the sum of today's HI for all the first authors from his/her laboratory on papers published during 1991 to 1995 with scientist X as the last author. As an example, for Kuan-Teh Jeang (KTJ) during the 1991–1995 period, there were eight different first authors who listed the same laboratory affiliation as KTJ and who published papers with KTJ as the last author. The eight individuals, (with current HI in parentheses) A. Gatignol (14), B. Berkhout (38), B. Dropulic (9). O.J. Semmes (27), Y.N. Chang (5), F. Majone (5), A. Joshi (2) and L.M. Huang (19), provide a total HI of 14 + 38 + 9 + 27 + 5 + 5 + 2 + 19 = 119. If one divides 119 by 8, a MI of 14.8 for KTJ is derived. This number could be used for comparing KTJ to others for mentoring contributions during a defined period (e.g. 1991 to 1995). Of course, comparisons are meaningful only when done amongst appropriate peer groups. A focus on using the HI of previous trainees in evaluating established scientists could encourage the development of long-lasting mentoring relationships that continue even after the trainees have departed the mentors' laboratories.

Frequency of citation versus frequency of access

The above discussions of HI, MI, citation frequencies, and impact factor presume the primacy of citations as a measure of scientific value. What if this presumption is off-the-mark? Is there another value that could be considered? In other areas of communication (book publishing, music distribution) where citation metrics are irrelevant, the numbers of readers (copies of books sold) and listeners (number of albums sold or songs downloaded) are used to gauge impact. In the modern internet era, the frequency of "hits" or accesses to portals such as YouTube or Facebook quantitatively gauges relative importance. In this respect, should the frequency of accesses to online Open Access scientific articles similarly matter? To begin to explore this question, I examined the top 15 "all time" most highly accessed papers at Retrovirology . In this dataset, four 2006 papers (excluding a meeting report, [4]) were identified that have been accessed 23,634; 8,592; 8,304; and 7,902 times respectively [5], [6], [7], [8]. These four highly accessed papers have been cited to date 14, 13, 15, and 14 times, placing them in the top 15% of cited Retrovirology papers published in 2006. On the other hand, the four Retrovirology papers published during 2006 that are currently the most frequently cited [9], [10], [11], [12] (cited 27, 23, 21, 20 times) are not the four which are the most highly accessed. Thus, high readership does seem to produce high citation frequency, but high citation frequency does not always require high readership. This pattern suggests that Open Access readers encompass those who simply read and those who read and also write papers that cite other papers. Citation numbers measure the latter group, while access numbers measure both groups. Arguably, it is unclear that a published paper's influence on one group (citations) counts while the less well-tabulated impact on the second group (accesses) counts not. The relative merits of citations versus accesses require further validation.

Acknowledgements

I thank Mark Wainberg, Andrew Lever, and Ben Berkhout for critical readings of this editorial. The values shown in Table 1 are to be viewed as illustrative examples and are not to be regarded as fully accurate. The views expressed are the author's personal opinion and do not represent the position of the author's employer, the National Institutes of Health, USA. Research in KTJ's laboratory is supported by NIAID Intramural funds. I thank Christina Bezon for assistance with Table 1.

Competing interests

The author declares that he has no competing interests.
  12 in total

1.  Does the H index have predictive power?

Authors:  J E Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

Review 2.  Anti-viral RNA silencing: do we look like plants?

Authors:  Anne Saumet; Charles-Henri Lecellier
Journal:  Retrovirology       Date:  2006-01-12       Impact factor: 4.602

Review 3.  The retrovirus RNA trafficking granule: from birth to maturity.

Authors:  Alan W Cochrane; Mark T McNally; Andrew J Mouland
Journal:  Retrovirology       Date:  2006-03-17       Impact factor: 4.602

Review 4.  HIV-1 associated dementia: symptoms and causes.

Authors:  Mohammad Ghafouri; Shohreh Amini; Kamel Khalili; Bassel E Sawaya
Journal:  Retrovirology       Date:  2006-05-19       Impact factor: 4.602

Review 5.  The discovery of endogenous retroviruses.

Authors:  Robin A Weiss
Journal:  Retrovirology       Date:  2006-10-03       Impact factor: 3.768

Review 6.  The cell biology of HIV-1 and other retroviruses.

Authors:  Eric O Freed; Andrew J Mouland
Journal:  Retrovirology       Date:  2006-11-03       Impact factor: 4.602

7.  Sometimes the impact factor outshines the H index.

Authors:  Johannes Hönekopp; Janet Kleber
Journal:  Retrovirology       Date:  2008-10-06       Impact factor: 4.602

8.  HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.

Authors:  Marie-Hélène Cavanagh; Sébastien Landry; Brigitte Audet; Charlotte Arpin-André; Patrick Hivin; Marie-Eve Paré; Julien Thête; Eric Wattel; Susan J Marriott; Jean-Michel Mesnard; Benoit Barbeau
Journal:  Retrovirology       Date:  2006-03-02       Impact factor: 4.602

9.  Impact factor, H index, peer comparisons, and Retrovirology: is it time to individualize citation metrics?

Authors:  Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2007-06-18       Impact factor: 4.602

10.  HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.

Authors:  Bradford K Berges; William H Wheat; Brent E Palmer; Elizabeth Connick; Ramesh Akkina
Journal:  Retrovirology       Date:  2006-11-01       Impact factor: 4.602

View more
  7 in total

1.  Prizes and heroes: lagging and leading indicators.

Authors:  Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2010-10-13       Impact factor: 4.602

2.  The Retrovirology Open Access experience.

Authors:  Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2009-12-15       Impact factor: 4.602

3.  The Hirsch index - a play on numbers or a true appraisal of academic output?

Authors:  Taimur Saleem
Journal:  Int Arch Med       Date:  2011-07-07

4.  Ranking Iranian biomedical research centers according to H-variants (G, M, A, R) in Scopus and Web of Science.

Authors:  Zoleikha Mahmudi; Iman Tahamtan; Shahram Sedghi; Masoud Roudbari
Journal:  Med J Islam Repub Iran       Date:  2015-06-07

5.  Scientific output quality of 40 globally top-ranked medical researchers in the field of osteoporosis.

Authors:  W Pluskiewicz; B Drozdzowska; P Adamczyk; K Noga
Journal:  Arch Osteoporos       Date:  2018-03-26       Impact factor: 2.617

6.  Comprehensive Researcher Achievement Model (CRAM): a framework for measuring researcher achievement, impact and influence derived from a systematic literature review of metrics and models.

Authors:  Jeffrey Braithwaite; Jessica Herkes; Kate Churruca; Janet C Long; Chiara Pomare; Claire Boyling; Mia Bierbaum; Robyn Clay-Williams; Frances Rapport; Patti Shih; Anne Hogden; Louise A Ellis; Kristiana Ludlow; Elizabeth Austin; Rebecca Seah; Elise McPherson; Peter D Hibbert; Johanna Westbrook
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

7.  The importance of individualized article-specific metrics for evaluating research productivity.

Authors:  Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2009-09-16       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.